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KAJIAN FITOKIMIA DAN BIOAKTIVITI TERHADAP 
MIMUSOPS ELENGI L. 
ABSTRAK 
Kajian fitokimia terhadap ekstrak kloroform daripada daun dan kulit Mimusops 
elengi telah berjaya mengasingkan spinasterol [15], asid ursolik [18] dan asid 3β,6β, 
19α,23-tetrahidroksiurs-12-en-28-oik [67] daripada daun, dan tarakserol [16] serta 
spinasterol 3-O-β-D-glukopiranosida [39] daripada kulit. Kajian terdahulu 
menunjukkan pengasingan sebatian [15] daripada kulit batang pokok dan biji benih 
pokok, sebatian [18] daripada kulit batang pokok and mesokarp, manakala sebatian 
[39] diasingkan daripada biji benih tumbuhan. Tetapi ini merupakan kajian pertama 
yang melaporkan pengasingan [15] dan [18] daripada daun, manakala [39] daripada 
kulit pokok. Sebatian [67] adalah tidak pernah dikenalpasti daripada M. elengi dan 
famili Sapotaceae. Analisis terhadap komponen mudah meruap daripada bunga 
melalui kaedah GC dan GC/MS menunjukkan kehadiran 50 sebatian dan didapati 
bahawa 2-feniletanol (29.8%), (E)-2-heksenal (11.8%) dan benzil alkohol (10.4%) 
merupakan sebatian terbanyak. Ekstrak kloroform daripada daun dan kulit, sebatian 
terasing dan minyak meruap bunga diuji untuk aktiviti antibakteria dengan 
menggunakan bakteria Gram-positif dan Gram-negatif, manakala aktiviti bengkak 
diuji menggunakan ujian siklooksigenase. Kebanyakan sampel yang diuji 
menunjukkan aktiviti yang baik terhadap Staphylococcus aureus (9.7-78 μg/mL) 
manakala aktiviti yang sederhana ditunjukkan terhadap bakteria Gram-negatif (78-
156 μg/mL). Perencatan COX yang tinggi didapati daripada ekstrak daun dan [15], 
perencatan selektif COX-2 didapati pada [18] dan [67], manakala perencatan selektif 
COX-1 ditunjukkan pada ekstrak kulit [39] dan minyak bunga. Kajian ini adalah 
yang pertama menjelaskan potensi M. elengi terhadap aktiviti bengkak. Keputusan 
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kajian ini menyokong penggunaan tumbuhan ini dalam Ayurvedic sebagai agen 
mentah antibakteria dan aktiviti bengkak. 
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PHYTOCHEMICAL AND BIOACTIVITY STUDIES OF 
MIMUSOPS ELENGI L. 
ABSTRACT 
Phytochemical investigation of the chloroform extracts of the leaves and bark of 
Mimusops elengi led to the isolation of spinasterol [15], ursolic acid [18] and 
3β,6β,19α,23-tetrahydroxyurs-12-en-28-oic acid [67] from the leaves, as well as 
taraxerol [16] and spinasterol 3-O-β-D-glucopyranoside [39] from the bark. 
Compound [15] has previously been reported from the bark and seeds, compound 
[18] has been reported from the bark and mesocarp, and compound [39] has been 
reported from seeds of the plant. However, this is the first report of [15] and [18] 
from the leaves and [39] from the bark. Compound [67] has not, hitherto, been 
identified in M. elengi and the family Sapotaceae. Analysis of the volatile 
constituents of the flowers by capillary GC and GC/MS resulted in the identification 
of 50 compounds, the most abundant of which were 2-phenylethanol (29.8%), (E)-2-
hexenal (11.8%) and benzyl alcohol (10.4%). The chloroform leaf and bark extracts, 
isolated compounds and flower volatile oil were tested for antibacterial activity using 
Gram-positive and Gram-negative bacteria, and anti-inflammatory activity using the 
cyclooxygenase assay. The majority of the samples tested indicated good activity 
against Staphylococcus aureus (9.7-78 μg/mL), while appreciable activity was 
observed against Gram-negative bacteria (78-156 μg/mL). Strong COX inhibition 
was observed for the leaf extract and [15], selective COX-2 inhibition was observed 
for [18] and [67], and selective COX-1 inhibition was observed for the bark extract, 
[39] and the flower oil. This study is the first report describing the anti-inflammatory 
potential of M. elengi. The results of this study support the Ayurvedic uses of the 
plant as crude antibacterial and anti-inflammatory agents. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Natural products 
Natural products are structurally diverse libraries of chemical constituents produced 
by all living organisms for their survival against predators and environment. Natural 
products and their derivatives are major sources of drug discovery in almost all 
therapeutic areas (Balunas and Kinghorn, 2005). Despite the research provided by 
other drug discovery methods, natural products are an inimitable source of drugs and 
pharmacological agents (Newman et al., 2000). A report by the world health 
organization suggested that approximately 80% of the world's population uses 
traditional medicines (Min et al., 1998). Research on natural products presently 
focuses on phytochemical investigations on plants of biomedical importance in folk 
medicine. 
 
1.2     Biosynthesis of terpenes 
Terpenes are secondary metabolites commonly found in almost all plants; they are 
derived from isoprenoid units. These isoprene units condense to form monoterpenes, 
sesquiterpenes, diterpenes, triterpenes and tetraterpenes. The two active forms of the 
isoprene unit are isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP) (Manitto, 1981). DMAPP condenses with IPP in the presence of 
dimethylallyl transferase to give geranyl pyrophosphate (GPP) and neryl 
pyrophosphate (NPP); GPP is the precursor of monoterpenes. GPP and IPP further 
condense to yield farnesyl pyrophosphate (FPP), which is the key intermediate of 
sesquiterpene synthesis (Jacob et al., 1983; Koyama et al., 1980; Poulter et al., 
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1979). The addition of another isopentyl unit to FPP gives geranylgeranyl 
pyrophosphate (GGPP) which is cyclized to give diterpenes. Two FPP dimerize in a 
tail to tail manner to give squalene which is the precursor for various triterpenes 
(Scheme 1.1) ( odr  guez-Concepción and Boronat, 2002).  
 
 
Scheme 1.1 Condensation of isopentene units to acyclic terpenoid 
 
Biosynthesis of pentacyclic triterpenes involves a series of Wagner-Meerwein 
rearrangements during the formation of D and E ring systems from the cyclization 
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intermediate of 2,3-oxidosqualene. The mechanism of D and E ring formation in 
case of β-amyrin synthesis involves backbone rearrangement and hydride shifts 
(Scheme 2.1) (Rees et al., 1968; Seo et al., 1981; Xu et al., 2004). 
 
 
 
 
 
 
Scheme 1.2 Cyclization of squalene 
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1.3 Sapotaceae 
This family comprises shrubs and trees that characteristically possess a milky sap. It 
consists of 35-75 genera, approximately 800 species distributed pantropically with a 
few species in temperate regions, while seven genera are native to the Malay 
Peninsula (Hsuan, 1969; Woodland, 1997).  The largest genera are Palanchonella, 
Palaquium and Pouteria with 100, 115 and 150 species, respectively. In Peninsular 
Malaysia the family is a source of timber; in Central America, Manilakara zapota 
provides chicle (the elastic component of chewing gum). Edible fruits such as the 
sapodilla plum and star apple are provided by Achras zapota and Chrysophyllum 
cainiti, respectively. The Upper Cretaceous and more recent deposits have indicated 
fossil pollens of this family (Woodland, 1997). 
 
1.3.1 Mimusops 
The genus Mimusops is native to tropical parts of Africa and Asia.  Parts of wood, 
flowers and fruits of this genus have also been found in ancient Egyptian tombs. 
Members of this genus possess chartaceous or coriaceous leaves, solitary or fascicled 
flowers and 1-4 seeded oblong pulpy fruits (Friis et al., 1986; Hutchings et al., 1996; 
Ridley and Hutchinson, 1967; Shahwar and Raza, 2009). 
 
1.3.1.1 Mimusops elengi L. 
Mimusops elengi (Figure 1.1) is an evergreen tree of Indian or Burmese origin. It is 
30 feet tall (Ridley and Hutchinson, 1967). The trunk divides into several limbs 
forming a thick scattering round crown. The greyish brown bark is deeply ridged and 
fissured. The leaves are arranged axially or alternately and are spaced along the 
twigs. The leaf is oblong elliptic, tipped, possesses wavy edges and a dull green 
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tenuous leathery stalk half to one inch long, while the blade is 2-6 inches long and 1-
3 inches wide. The flowers are half an inch wide, fragrant, shortly stalked and are 
usually found in auxiliary clusters of 2-6 flowers. Their white petals are arranged in 
a star like ring which appear to be dropping down (Corner, 1988). The oblong, 
pointed, smooth, fleshy fruit is one inch long (Ridley and Hutchinson, 1967), which 
upon ripening turns orange red from green. It possesses eight persistent sepals at the 
base and contains one hard blackish brown seed (Corner, 1988). M. elengi is 
cultivated throughout the tropics (Corner, 1988) and is presumably wild in Pahang, 
Malaysia (Ridley and Hutchinson, 1967). 
 
 
Figure 1.1 Mimusops elengi L.  
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1.4 Medicinal properties of M. elengi 
Diverse medicinal properties have been reported for different parts of the plant. The 
leaves are used for treating cholagouge, stomache and act as antihelmintic. The juice 
of the leaves is also applicable to wounds. The leaves and stem are cooked with pork 
to yield a tonic and the leaves are further presumed to treat snake bite. The leaves are 
also known to possess antioxidant and anti-inflammatory properties (Ambasta et al., 
1986; Chopra et al., 1956; Dastur, 1962; Saha et al., 2008). 
 
The bark is styptic and astringent thus its decoction is handy in catarrh of the bladder 
and urethra. As a febrifuge it is given in fevers and used to increase female fertility. 
The decoction also treats diseases of the gums, sore mouth and is also utilized as an 
antidiuretic, antitoxin and a premature-ejaculation suppressor (Dastur, 1962; 
Paranjepe, 2001; Sharma et al., 2000). The bark and the leaf extracts are known to 
possess potent antibacterial and antifungal activities (Ali et al., 2008; Shahwar and 
Raza, 2009). 
 
A paste of the root prepared with vinegar is applied to swellings on the face, and a 
paste prepared with water is used as a dressing for pustular skin eruptions (Dastur, 
1962). The aqueous flower distillate is valued as a perfume. The flowers are used for 
treating heart disease, while wounds and ulcers are also bathed with an astringent 
flower lotion. The dried powdered flowers are used as a snuff for relief from 
cephalagia. The flower extract of M. elengi administrated in anesthetized dogs was 
found to exhibit diuretic action (Dastur, 1962; Kanjanapothi and Tejasen, 1971; 
Paranjepe, 2001; Sharma et al., 2000).  
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Mastication of the unripe fruit is practical for strengthening and fixing loose teeth, 
while ripe fruit pulps are helpful in chronic dysentery. The fruit is used externally for 
headache and its lotion can be applied to wounds and sores. Preserves and pickles 
are also produced from the fruit. The fruit possesses significant antioxidant capacity 
and radical scavenging effect, the green fruit showing greater antioxidant capacity 
and phenolic content as compared to the orange-ripe fruit (Boonyuen et al., 2009; 
Chaovanamethakul et al., 2007; Kumar and Arora, 2007). 
 
The blend of the seeds in oil is supposedly practical in obstinate constipation, 
particularly in children (Ambasta et al., 1986; Chopra et al., 1956; Dastur, 1962), 
while saponins extracted from the roots, leaves, fruits, seeds, and bark showed a 
moderate degree of spasmolytic activity (Banerji et al., 1982). The plant is also 
reported to possess antibacterial, anti-diabetic and antifungal properties (Ganu and 
Jadhav, 2010; Rao et al., 2009; Mohamed et al., 1996; Satish et al., 2008).  
 
1.5 Previous studies on M. elengi 
A literature survey indicated that all the plant parts of M. elengi have been 
investigated previously. However, the seeds were focused extensively and triterpenes 
were the most commonly found compounds. 
 
1.5.1 Phytochemical studies on M. elengi 
The earliest investigations began in 1910 when Kesava-Menon isolated a volatile oil 
from the flowers which on extraction with ether extract yielded 18.47% of a 
yellowish brown oil (Kesava-Menon, 1910). Later, Rau and Simnsen isolated 
behenic acid (1), palmitic acid (2), stearic acid (3) and oleic acid (4) from the seed 
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oil (Rau and Simnsen, 1922).  The petroleum ether extract of the seeds also yielded 
linoleic acid (5), arachidic acid (6), lauric acid (7), myristic acid (8) and β-sitosterol 
(9) apart from the previously reported oleic acid (4), palmitic acid (2) and stearic 
acid (3) (Sinha, 1962). 
 
CH3(CH2)nCOOH 
(1) n = 20 
(2) n = 14 
(3) n = 16 
(6) n = 18 
(7) n = 10 
(8) n = 12 
 
  
(4) 
 
 
 
 
 
(5) 
 
(9) 
 
Misra and Mitra investigated all the parts of the plant and the following compounds 
were identified: betulinic acid (10), lupeol (11), quercitol (13), β-sitosterol glucoside 
(14), spinasterol (15), taraxerol (16), taraxerone (17) and ursolic acid (18) from the 
bark, hederagenin (19), lupeol (11) and α-spinasterol (15) from the heart-wood, 
hentriacontane (20), β-carotene (21) and quercitol (13) from the leaves, lupeol 
acetate (12), and taraxerol (16) from the root, quercitol (13) and ursolic acid (18) 
from the mesocarp, quercetin (22), dihydroquercetin (23), β-sitosterol glucoside  (14) 
and quercitol (13) from the testa, β-sitosterol glucoside (14), quercitol (13) and α-
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spinasterol (15) from the kernel (Misra and Mitra, 1967a; Misra and Mitra, 1967b; 
Misra and Mitra, 1968). 
 
 
(10) R1 = OH, R2 = COOH 
(11) R1 = OH, R2 = CH3 
 
 
(12) R1 =                    , R2 = CH3 
 
 
 
 
 
 
(13) 
 
(14) 
 
 
(15) 
 
 
(16) R = β-OH 
(17) R = -O 
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(18) 
 
 
(19) 
 
CH3(CH2)29CH3 
 (20) 
 
 
(21) 
 
 
 
(22) 
 
(23) 
 
A mixture of saponins was isolated from the bark which on hydrolysis yielded β-
amyrin (24) and bassic acid (25) (Varshney and Logani, 1969). Subramanian and 
Nair indicated the presence of myricetin 3-O-L-rhamnoside (26) and myricetin 3-O-
β-D-galactoside (27) in the ethanol extract of the plant (Subramanian and Nair, 
1973). D-mannitol (28), β-sitosterol (9) and β-sitosterol-D-glucoside (14) were 
reported from the flowers. However, their identification was based on melting point, 
thin-layer chromatography and IR spectroscopy (Gupta et al., 1976). A new steroidal 
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saponin 5β-stigmast-9(11)-en-3-O-β-D-glucopyranosyl (15)-O-β-D xylofuranoside 
(29) was isolated from the roots (Saxena and Shrivastava, 1988). 
 
 
(24) 
 
 
(25) 
 
 
(26) R = α-L-rhamnosyl 
(27) R = β-D-galactosyl 
 
 
 
 
(28) 
 
 
 
 
(29) 
 
Mandal and Maity reported behenic acid (1), linoleic acid (5), oleic acid (4), palmitic 
acid (2) and stearic acid (3) from the seed kernels (Mandal and Maity, 1991). Later, 
Sen et al. isolated from the seeds new pentacyclic triterpenes, mimugenone (30), 
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mimusopgenone (31), mimusopic acid (32) and mimusopsic acid (33) (Sen et al., 
1993; Sen et al., 1995). Sahu isolated from the seeds two saponins, mimusopside A 
(34) and mimusopside B (35), in addition to dihydroquercetin (23), Mi-glycoside 
(36) and α-spinasterol glucoside (37) (Sahu, 1996; Sahu, 1995).  
 
Jahan et al. isolated (24R)-5α-stigmasta-7,22(E)-dien-3α-ol (C-3 epimer of 
chondrillasterol) (38), spinasterol glucopyranoside (39), spinasterol 
galactopyranoside (40) and 3β-hydroxy-lup-20(29)-ene-23, 28-dioic acid (41), in 
addition to β-amyrin (24), lupeol (11), taraxerol (16) and ursolic acid (18) from the 
plant (Jahan et al., 1995a; Jahan et al., 1995b; Jahan et al., 1996). 
 
 
(30) R1 = H, R2 = O, R3 = CH3 Δ
5,12
 
(31) R1 = OH, R2 = O, R3 = H Δ
5,12 
(32) R1 = OH, R2 = H, R3 = COOH Δ
10,12
 
 
 
(33) 
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(34) R1 = β-D-glucopyranosyl, R2 = H, R3 = α-L-rhamnopyranosyl (12)-α-L-
arabinopyranosyl 
(35) R1 = β-D-glucopyranosyl, R2 = OH, R3 = α-L-rhamnopyranosyl (12)-α-L-
arabinopyranosyl 
(36) R1 = β-D-glucopyranosyl, R2, R3 = H 
 
 
(37) R = β-D-glucosyl 
 
 
(38)  R = H, (24R) 
( 39) R = β-D-glucopyranosyl, (24R) 
(40)  R = β-D-galactopyranosyl, (24R) 
 
 
(41) 
 
In addition to Mi-saponin A (42) and 16α-hydroxy Mi-saponin A (43), Sahu et al. 
identified two novel triterpenoid saponins, mimusopin (44) and mimusopsin (45), 
and two novel minor triterpenoid saponins mimusin (46) and elengin (47) (Sahu et 
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al., 1995; Sahu et al., 1997; Sahu et al., 1998). Later, a new triterpene, mimusic acid 
(48), and the known mimusopic acid (33) were also reported (Sahu et al., 1999). 
 
Two new triterpenes, 3β-(p-hydroxy-cis-cinnamoyloxy)-urs-12-en-28-oic acid (49) 
and 3β, 19β, 23-trihydroxy-urs-12-ene (51), were reported for the first time together 
with 3β-(p-hydroxy-trans-cinnamoyloxy)-urs-12-en-28-oic acid (50), 3β,6β,19α,23-
tetrahydroxy-urs-l2-ene (52), 1-β-hydroxy-3β-hexanoyllup-20 (29)-ene-23, 28-dioic 
acid (53) and ursolic acid (Jahan et al., 2000; Jahan et al., 2001). The fatty oils of M. 
elengi were found to consist of myristic acid (8), oleic acid (4), palmitic acid (2), 
stearic acid (3) and a new compound 9-keto-octadec-15(Z)-enoic acid (54) 
(Daulatabad and Bhat, 2003). Hazar et al. identified the known flavones quercetin 
(22) and dihydroquercetin (23) from the seeds, both indicating strong antibacterial 
activity (Hazra et al., 2007).  
 
 
(42) R1 =  R2  = R3 = R4 = H 
(43) R1 =  R2  = H, R3 = OH, R4 = H 
(44) R1 =  R2  = R3 = H, R4 = α-L-rhamnosyl 
(45) R1 =  H, R2  = β-D-glucopyranosyl, R3 = R4 = H 
(46) R1 =  β-D-glucopyranosyl, R2  = R3 = R4 = H 
(47) R1 =  β-D-glucopyranosyl, R2  = H, R3 = OH, R4 = H 
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(48) 
 
(49) R = p-hydroxy-cis-cinnamoyloxy 
(50) R = p-hydroxy-trans-cinnamoyloxy 
 
 
(51) R = H 
(52) R = β-OH 
 
(53) 
 
 
(54) 
 
Akhtar et al. identified from the bark elengigallate (55), mimusopstannin (56), 
elengitannin (57), gallic acid diglucoside (58), gallic acid phenoxy diglucoside (59), 
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elengibenzyl diglycoside (60), gallic acid triphenoxy diglycoside (61), 
mimusopfarnanol (62), farnan-3-one (63), lupeol, olean-18-en-2-one-3-ol (64), β-
sitosterol, β-sitosterol glucopyranoside, stigmasta-5,22-dien-3β-ol-3β-D-
glucuropyranosyl-(6'β1'')-D-glucopyranoside (65) and β-sitosterol-3β-(3''',6''',7'''-
trihydroxynaphthyl-2'''-carboxyl)-4''-glucopyranosyl-(1''4')-glucopyranoside (66) 
(Akhtar et al., 2009; Akhtar et al., 2010a; Akhtar et al., 2010b). 
 
 
(55) 
 
 
 
 
 
 
 
(56) R1 = H, R2 =   
 
 
 
 
 
 
 
(57) R1 = 
 
 
 
 
 
R2 = 
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(58) R1 = H, R2 = 
 
  
 
 
 
 
 
(59) R1 = H, R2 = 
 
 
 
 
 
 
 
(60) R1 = H, R2 = 
 
 
 
 
 
 
 
 
 
(61) R1 = 
 
 
 
 
R2 = 
 
 
 
 
 
 
(62) R1 = O, R2 = β-OH 
(63) R1 = H, R2 = O 
 
(64) 
 
 
(65) 
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(66) 
 
1.5.2 Studies on the volatile constituents of M. elengi 
Wong and Teng (1994) identified a total of 74 compounds among the volatile 
constituents of the flowers. The major constituents of headspace extraction were 2-
phenylethanol (37.8%), methyl benzoate (13.4%), p-methylanisole (9.9%) and 2-
phenylethyl acetate (7.1%), respectively, and those of solvent extraction were 2-
phenylethanol (38.7%), (E)-cinnamyl alcohol (13.7%) and 3-hydroxy-4-phenyl-2-
butanone (4.7%), respectively. 
 
Aromdee and Rattanadon (2009) investigated the volatile constituents of the dried 
and fresh flowers of M. elengi, the dried flowers gave a long chain carboxylic acid 
ester (5.3%) and (Z)-9-octadecenoic acid (4.7%), while the fresh flowers yielded 2-
phenylethanol (10.4%), 4-hydroxybenzyl alcohol (8.6%) and cinnamyl alcohol 
(6.1%). 
 
Rout et al. (2010) identified 27 compounds in a comparative study on the flower 
fragrance obtained from the water-soluble volatile, hexane and liquid carbon dioxide 
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extracts using GC and GC/MS. Major constituents such as phenol, benzyl alcohol, 2-
phenylethyl alcohol, anisyl alcohol, E-cinnamyl alcohol and ethyl p-anisate were 
found in varying percentages in the different extracts. The study focused on the 
proportions of benzenoids and waxy materials obtained from the different extracts. 
The hexane extract (concrete) was partitioned with methanol to give hexane extract 
absolute. The absolute and concrete hexane extracts contained waxy materials (30%) 
and benzenoids (45-51%). The water-soluble volatile extract was partitioned with 
diethyl ether to give a diethyl ether extract which contained a higher quantity of 
benzenoids, but their yield was low. The liquid carbon dioxide extract of the dried 
flowers contained waxy materials (60%) and benzenoids (14%). The liquid carbon 
dioxide extract of the fresh flowers showed the most promising results with 15% of 
waxy materials and 61% of benzenoids. Certain components such as heptanal, 
phenol, p-cresol, dimethyl ether, p-methoxycresol, p-anisaldehyde, anisyl alcohol, 
carvacrol, ethyl p-anisate, methyl palmitoleate, methyl palmitate, ethyl palmitoleate, 
palmitic acid, heneicosane, 6,13-octadecadienyl acetate, ethyl stearate and 5-
methyltricosane had not been reported previously from the flowers. The examination 
of the volatile constituents of the bark indicated the presence of α-cadinol, T-
muurolol and hexadecanoic acid as the major constituents (Ruikar et al., 2009). 
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1.6 Objectives of the present work 
The objectives of the present work are: 
1. To isolate and identify chemical constituents from the chloroform extracts of 
the bark and leaves of M. elengi. 
2. To determine the composition of the volatile constituents of the flowers of M. 
elengi isolated by low temperature vacuum distillation. 
3. To evaluate the antibacterial and anti-inflammatory activities of the crude 
chloroform extracts, isolated compounds and flower volatile oil. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Plant materials 
The bark, flowers and leaves of M. elengi were collected from the USM campus. The 
plant was identified by Mr. Baharuddin Sulaiman of the School of Biological 
Sciences, USM, Penang, Malaysia, where a voucher specimen (USM 9255) has been 
deposited. 
 
2.2 Extraction of the leaves 
Fresh leaves (3 kg) were macerated in 30 L of MeOH-H2O (4:1 v/v). The extract 
after filtration was concentrated under reduced pressure at a bath temperature <40ºC 
to 1/10 of its original volume using a rotary evaporator, acidified with aqueous 2M 
H2SO4 to a pH of 2-3, and 500 mL portions of it extracted with chloroform (200 × 2 
mL, then 100 mL) to give a combined chloroform extract of 31 g (1.03% w/w of 
fresh leaves) (Harborne, 1998). 
   
2.3 Extraction of the bark 
Fresh bark (4 kg) was dried in the shade for two weeks at room temperature (28ºC) 
to yield 1 kg of dry bark, which was powdered using a commercial crusher, and 150 
g each was extracted using a Soxhlet extractor with hexane for 4 hrs, then with 
chloroform for 8 hrs, yielding a combined chloroform extract of 14 g (0.35% w/w of 
fresh bark). 
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2.4 Isolation of the flower volatiles 
Intact flowers (350 g) collected 30 min earlier were immersed in distilled water and 
vacuum-distilled for 6 hrs, yielding approximately 250 mL of distillate which was 
collected in a liquid-nitrogen-cooled trap. Two small liquid-nitrogen-cooled traps 
connected in series between the first trap and the vacuum pump were used for 
preventing the back diffusion of impurities (Figure 2.1) (Joulain, 1987). The 
distillate was extracted with freshly-distilled dichloromethane (5 × 20 mL). The 
dichloromethane extract was then concentrated using a Kuderna-Danish concentrator 
at a bath temperature of 50ºC, and was carefully reduced to a volume of 0.1 mL 
under a gentle stream of high purity N2 gas at room temperature prior to gas 
chromatographic analysis. 
 
 
Figure 2.1 Vacuum-distillation of M. elengi flowers 
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2.5 Chromatography 
2.5.1 Thin layer chromatography 
Thin layer chromatography was used for the preliminary screening of the crude 
extracts, for the determination of a suitable solvent system for the subsequent 
column chromatographic separations, and for the purity determination of the isolated 
compounds. Pre-coated TLC plates (20 × 20 cm, coated with 0.2 mm silica gel F254 
on aluminium sheets, Merck) were cut into smaller pieces of 5.0 cm × 2.0 cm, which 
were used throughout this work. For visualization, a UV lamp (Vilber Lourmet, 
multiband UV-254/356 nm) was used. Additionally, 95% methanolic sulphuric acid 
was used as a detection reagent, in which plates after dipping were charred using a 
heat gun (Jork et al., 1990; Kirchner et al., 1951). 
  
2.5.2 Column chromatography 
Column chromatography (CC) was used to separate the chemical constituents of the 
crude extracts and for the isolation of pure compounds. Silica gel 60 (0.040-0.060 
mm, 230-400 mesh ASTM, Merck) was used as the adsorbent. Samples were either 
dissolved in a minimum quantity of a suitable solvent and adsorbed onto the silica 
gel by drying on a rotary evaporator to yield a powdered material which was loaded 
on the stationary phase, or were dissolved in a suitable solvent and applied to the top 
of the stationary phase (Sharp et al., 1989). 
 
2.6 Instrumentation 
2.6.1 Specific optical rotation measurement 
The specific optical rotations  of the isolated compounds were determined 
using an ATAGO AP-300 automatic polarimeter. A solution of 1.0% sucrose was 
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used as a standard and the sodium lamp was set at 589 nm. Samples were dissolved 
in chloroform and/or methanol according to their solubility and a cell of length 200 
mm was used for the measurements which were all taken at room temperature 
(25ºC). 
 
2.6.2 Melting point determination 
A Stuart scientific SMP-1 melting point apparatus was used for the melting point 
measurements. 
 
2.6.3 Infrared spectroscopy 
Infrared (IR) spectra were recorded on a Perkin-Elmer System 2000 FT-IR 
spectrometer. The sample was pressed with potassium bromide (KBr) to form a disk 
which was scanned in the range 4000-650 cm
-1
.  
 
2.6.4 Direct-probe mass spectrometry 
The electron impact (EI) and fast atom bombardment (FAB) mass spectra were 
recorded using an Agilent 5975C MSD and a Thermo Finnigan MAT95XL mass 
spectrometer, respectively. 
 
2.6.5 Nuclear magnetic resonance spectroscopy 
NMR spectra were recorded using a Bruker Avance 400 spectrometer operated at 
400 MHz for 1H and 2D NMR experiments (
1
H-
1
H-COSY, HMQC, HMBC, 
NOESY), and at 100 MHz for 
13
C NMR and DEPT  experiments (DEPT 90 and 
DEPT 135). The samples were dissolved in an appropriate solvent [chloroform-d 
(Merck), methanol-d4 (Acros Organics) and pyridine-d5 (Sigma-Aldrich)] with 
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tetramethylsilane (TMS) as internal standard, and placed in 5 × 180 mm NMR tubes 
(Sharp et al., 1989). 
 
2.7 Column chromatography of chloroform leaf extract  
The chloroform extract (31 g) was fractionated using silica gel column 
chromatography. Fifteen grams of each of the extracts absorbed on silica gel were 
loaded on a 100 × 15 cm glass column packed with 360 g of silica gel. The column 
was eluted using a hexane : ethyl acetate : methanol gradient (1:0:0  0:0:1 v/v/v). 
The eluates were collected in test tubes in 150 mL portions which were combined 
into ten fractions (F1 to F10) on the basis of TLC profile, and the solvent mixture 
was evaporated under reduced pressure: F1 (test tubes 1-7, 0.9 g, yellow oil, eluted 
with 100% hexane), F2 (test tubes 8-18, 1.3 g, yellow oil, eluted with hexane : ethyl 
acetate 9:1 v/v), F3 (test tubes 19-27, 1.1 g,  green solid, eluted with hexane : ethyl 
acetate 8:2 v/v), F4  (test tubes 28-35, 1.0 g, green solid, eluted with hexane : ethyl 
acetate 6:4 v/v), F5 (test tubes 36-47, 1.0 g, green solid, eluted with hexane : ethyl 
acetate 4:6 v/v), F6 (test tubes 48-54, 1.0 g, green solid, eluted with hexane : ethyl 
acetate 2:8 v/v), F7 (test tubes 55-61, 1.6 g, green solid, eluted with 100% ethyl 
acetate), F8 (test tubes 61-64, 1.0 g, white solid, eluted with ethyl acetate : methanol 
8:2 v/v), F9 (test tubes 65-76, 1.0 g, brown liquid, eluted with ethyl acetate : 
methanol 5:5 v/v) and F10 (test tubes 77-79, 2.0 g, brown liquid, eluted with 100% 
methanol). 
 
Fraction F2 (1.3 g) was rechromatographed using a 60 × 8 cm glass column packed 
with 30 g silica gel and eluted with hexane : ethyl acetate (1:0  7:3 v/v). A total of 
16 fractions (fr 1-16) were obtained, each 25 mL, which were combined into three 
